{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:54:37Z","timestamp":1790175277730,"version":"4.1.0"},"reference-count":79,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.revmed.2013.09.012","type":"journal-article","created":{"date-parts":[[2013,10,21]],"date-time":"2013-10-21T08:15:29Z","timestamp":1382343329000},"page":"413-420","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Myasth\u00e9nie et auto-anticorps\u00a0: physiopathologie des diff\u00e9rentes entit\u00e9s"],"prefix":"10.1016","volume":"35","author":[{"given":"S.","family":"Berrih-Aknin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Le Panse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2013.09.012_bib0005","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1471-2377-10-46","article-title":"A systematic review of population based epidemiological studies in myasthenia gravis","volume":"10","author":"Carr","year":"2010","journal-title":"BMC Neurol"},{"key":"10.1016\/j.revmed.2013.09.012_bib0010","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1001\/archneur.1991.00530190081019","article-title":"Epidemiology of myasthenia gravis in Denmark. A longitudinal and comprehensive population survey","volume":"48","author":"Somnier","year":"1991","journal-title":"Arch Neurol"},{"key":"10.1016\/j.revmed.2013.09.012_bib0015","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1212\/01.WNL.0000050461.05432.C5","article-title":"Myasthenia gravis: a higher than expected incidence in the elderly","volume":"60","author":"Aragones","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2013.09.012_bib0020","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1007\/s00415-010-5651-z","article-title":"Myasthenia gravis: a changing pattern of incidence","volume":"257","author":"Casetta","year":"2010","journal-title":"J Neurol"},{"key":"10.1016\/j.revmed.2013.09.012_bib0025","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1136\/jnnp.2006.100545","article-title":"Clinical and serological study of myasthenia gravis in HuBei Province, China","volume":"78","author":"Zhang","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.revmed.2013.09.012_bib0030","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/ana.410210309","article-title":"Heterogeneity in myasthenia gravis: HLA phenotypes and autoantibody responses in ocular and generalized types","volume":"21","author":"Kida","year":"1987","journal-title":"Ann Neurol"},{"key":"10.1016\/j.revmed.2013.09.012_bib0035","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1212\/WNL.34.1.66","article-title":"Anti-AChR antibodies, thymic histology, and T cell subsets in myasthenia gravis","volume":"34","author":"Berrih","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2013.09.012_bib0040","first-page":"6","article-title":"Role of the thymus in the physiopathology of myasthenia","volume":"151","author":"Eymard","year":"1995","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.revmed.2013.09.012_bib0045","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1210\/en.2004-1003","article-title":"Differential estrogen receptor expression in autoimmune myasthenia gravis","volume":"146","author":"Nancy","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.revmed.2013.09.012_bib0050","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1600-0404.1989.tb03881.x","article-title":"Associated disorders in myasthenia gravis: autoimmune diseases and their relation to thymectomy","volume":"80","author":"Thorlacius","year":"1989","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.revmed.2013.09.012_bib0055","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s004150050604","article-title":"Muscle autoantibodies in subgroups of myasthenia gravis patients","volume":"247","author":"Romi","year":"2000","journal-title":"J Neurol"},{"key":"10.1016\/j.revmed.2013.09.012_bib0060","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1468-1331.2007.01785.x","article-title":"Myasthenia gravis patients with ryanodine receptor antibodies have distinctive clinical features","volume":"14","author":"Romi","year":"2007","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.revmed.2013.09.012_bib0065","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1212\/WNL.38.1.138","article-title":"Neonatal myasthenia gravis: a new clinical and immunologic appraisal on 30\u00a0cases","volume":"38","author":"Morel","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2013.09.012_bib0070","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0092-8674(00)81251-9","article-title":"The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo","volume":"85","author":"DeChiara","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.revmed.2013.09.012_bib0075","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/35074025","article-title":"Distinct roles of nerve and muscle in postsynaptic differentiation of the neuromuscular synapse","volume":"410","author":"Lin","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.revmed.2013.09.012_bib0080","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1093\/brain\/awg223","article-title":"Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis","volume":"126","author":"Evoli","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.revmed.2013.09.012_bib0085","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ana.20386","article-title":"Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG","volume":"57","author":"Leite","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.revmed.2013.09.012_bib0090","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.cell.2008.10.002","article-title":"Lrp4\u00a0is a receptor for Agrin and forms a complex with MuSK","volume":"135","author":"Kim","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.revmed.2013.09.012_bib0095","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ana.22312","article-title":"Autoantibodies to low-density lipoprotein receptor-related protein 4\u00a0in myasthenia gravis","volume":"69","author":"Higuchi","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.revmed.2013.09.012_bib0100","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archneurol.2011.2393","article-title":"Autoantibodies to lipoprotein-related protein 4\u00a0in patients with double-seronegative myasthenia gravis","volume":"69","author":"Zhang","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.revmed.2013.09.012_bib0105","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1001\/archneurol.2012.437","article-title":"Presence and pathogenic relevance of antibodies to clustered acetylcholine receptor in ocular and generalized myasthenia gravis","volume":"69","author":"Jacob","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.revmed.2013.09.012_bib0110","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1093\/brain\/awn092","article-title":"IgG1\u00a0antibodies to acetylcholine receptors in \u201cseronegative\u201d myasthenia gravis","volume":"131","author":"Leite","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.revmed.2013.09.012_bib0115","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1749-6632.2012.06833.x","article-title":"The search for new antigenic targets in myasthenia gravis","volume":"1275","author":"Cossins","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.revmed.2013.09.012_bib0120","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jneuroim.2010.10.024","article-title":"Reduced thymic expression of ErbB receptors without auto-antibodies against synaptic ErbB in myasthenia gravis","volume":"232","author":"Vrolix","year":"2011","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.revmed.2013.09.012_bib0125","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/mus.880080311","article-title":"Measurement of junctional acetylcholine receptors in myasthenia gravis: clinical correlates","volume":"8","author":"Pestronk","year":"1985","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.revmed.2013.09.012_bib0130","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0022-510X(83)90095-3","article-title":"Anti-acetylcholine receptor antibodies in myasthenia gravis. Part 1. Relation to clinical parameters in 250\u00a0patients","volume":"58","author":"Limburg","year":"1983","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.revmed.2013.09.012_bib0135","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1212\/WNL.43.6.1167","article-title":"Myasthenia gravis: quantitative immunocytochemical analysis of inflammatory cells and detection of complement membrane attack complex at the end-plate in 30\u00a0patients","volume":"43","author":"Nakano","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2013.09.012_bib0140","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1126\/science.186.4158.55","article-title":"Serum globulin in myasthenia gravis: inhibition of alpha-bungarotoxin binding to acetylcholine receptors","volume":"186","author":"Almon","year":"1974","journal-title":"Science"},{"key":"10.1016\/j.revmed.2013.09.012_bib0145","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1126\/science.850793","article-title":"Myasthenic immunoglobulin accelerates acetylcholine receptor degradation","volume":"196","author":"Kao","year":"1977","journal-title":"Science"},{"key":"10.1016\/j.revmed.2013.09.012_bib0150","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1172\/JCI117302","article-title":"Regulation of acetylcholine receptor alpha subunit variants in human myasthenia gravis. Quantification of steady-state levels of messenger RNA in muscle biopsy using the polymerase chain reaction","volume":"94","author":"Guyon","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.revmed.2013.09.012_bib0155","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1172\/JCI1248","article-title":"Regulation of acetylcholine receptor gene expression in human myasthenia gravis muscles. Evidences for a compensatory mechanism triggered by receptor loss","volume":"102","author":"Guyon","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.revmed.2013.09.012_bib0160","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jneuroim.2004.08.002","article-title":"The role of complement in myasthenia gravis: serological evidence of complement consumption in vivo","volume":"158","author":"Romi","year":"2005","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.revmed.2013.09.012_bib0165","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.autrev.2013.03.003","article-title":"Complement associated pathogenic mechanisms in myasthenia gravis","volume":"12","author":"Tuzun","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.revmed.2013.09.012_bib0170","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jneuroim.2012.01.003","article-title":"DAF\/CD55\u00a0and Protectin\/CD59\u00a0modulate adaptive immunity and disease outcome in experimental autoimmune myasthenia gravis","volume":"244","author":"Soltys","year":"2012","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.revmed.2013.09.012_bib0175","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/ana.21536","article-title":"Novel complement inhibitor limits severity of experimentally myasthenia gravis","volume":"65","author":"Soltys","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.revmed.2013.09.012_bib0180","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jneuroim.2008.01.013","article-title":"Clinical fluctuations in MuSK myasthenia gravis are related to antigen-specific IgG4\u00a0instead of IgG1","volume":"195","author":"Niks","year":"2008","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.revmed.2013.09.012_bib0185","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/ana.21371","article-title":"Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction","volume":"63","author":"Cole","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1016\/j.revmed.2013.09.012_bib0190","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/brain\/aws025","article-title":"Muscle-specific kinase myasthenia gravis IgG4\u00a0autoantibodies cause severe neuromuscular junction dysfunction in mice","volume":"135","author":"Klooster","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.revmed.2013.09.012_bib0195","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1212\/WNL.0b013e318237f660","article-title":"Anti-MuSK autoantibodies block binding of collagen Q to MuSK","volume":"77","author":"Kawakami","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2013.09.012_bib0200","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jneuroim.2006.05.017","article-title":"Major pathogenic effects of anti-MuSK antibodies in myasthenia gravis","volume":"177","author":"Boneva","year":"2006","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.revmed.2013.09.012_bib0205","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.2353\/ajpath.2009.090040","article-title":"The effect of plasma from muscle-specific tyrosine kinase myasthenia patients on regenerating endplates","volume":"175","author":"ter Beek","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.revmed.2013.09.012_bib0210","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/ni723","article-title":"Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self","volume":"2","author":"Derbinski","year":"2001","journal-title":"Nat Immunol"},{"key":"10.1016\/j.revmed.2013.09.012_bib0215","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/sj.cdd.4401611","article-title":"Thymic myoid cells protect thymocytes from apoptosis and modulate their differentiation: implication of the ERK and Akt signaling pathways","volume":"12","author":"Le Panse","year":"2005","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.revmed.2013.09.012_bib0220","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1084\/jem.191.6.1051","article-title":"An essential role for thymic mesenchyme in early T cell development","volume":"191","author":"Suniara","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.revmed.2013.09.012_bib0225","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1749-6632.1987.tb51282.x","article-title":"The role of the thymus in myasthenia gravis: immunohistological and immunological studies in 115\u00a0cases","volume":"505","author":"Berrih-Aknin","year":"1987","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.revmed.2013.09.012_bib0230","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/ana.21628","article-title":"CCL21\u00a0overexpressed on lymphatic vessels drives thymic hyperplasia in myasthenia","volume":"66","author":"Berrih-Aknin","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.revmed.2013.09.012_bib0235","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1182\/blood-2005-06-2383","article-title":"The chemokine CXCL13\u00a0is a key molecule in autoimmune myasthenia gravis","volume":"108","author":"Meraouna","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2013.09.012_bib0240","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.imbio.2012.05.006","article-title":"SDF-1\/CXCL12\u00a0recruits B cells and antigen-presenting cells to the thymus of autoimmune myasthenia gravis patients","volume":"218","author":"Weiss","year":"2013","journal-title":"Immunobiology"},{"key":"10.1016\/j.revmed.2013.09.012_bib0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2013.03.007","article-title":"The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes","author":"Marx","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.revmed.2013.09.012_bib0250","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.autrev.2013.03.011","article-title":"Ectopic germinal centers, BAFF and anti-B cell therapy in myasthenia gravis","volume":"12","author":"Berrih-Aknin","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.revmed.2013.09.012_bib0255","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1172\/JCI115843","article-title":"Transplantation of thymic autoimmune microenvironment to severe combined immunodeficiency mice. A new model of myasthenia gravis","volume":"90","author":"Schonbeck","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.revmed.2013.09.012_bib0260","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/1531-8249(199910)46:4<559::AID-ANA3>3.0.CO;2-S","article-title":"Prevention of autoimmune attack by targeting specific T-cell receptors in a severe combined immunodeficiency mouse model of myasthenia gravis","volume":"46","author":"Aissaoui","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.revmed.2013.09.012_bib0265","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1007\/s00415-013-6880-8","article-title":"Thymectomy: role in the treatment of myasthenia gravis","volume":"260","author":"Spillane","year":"2013","journal-title":"J Neurol"},{"key":"10.1016\/j.revmed.2013.09.012_bib0270","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0003-4975(01)02678-9","article-title":"Predictors of outcome in thymectomy for myasthenia gravis","volume":"72","author":"Budde","year":"2001","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.revmed.2013.09.012_bib0275","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/S0003-4975(99)00310-0","article-title":"Prognostic factors for myasthenia gravis treated by thymectomy: review of 61\u00a0cases","volume":"67","author":"Nieto","year":"1999","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.revmed.2013.09.012_bib0280","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1016\/S0022-5223(03)00938-3","article-title":"The immunologic role of thymectomy in the treatment of myasthenia gravis: implication of thymus-associated B-lymphocyte subset in reduction of the anti-acetylcholine receptor antibody titer","volume":"126","author":"Okumura","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.revmed.2013.09.012_bib0285","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1196\/annals.1405.014","article-title":"Status of the thymectomy trial for nonthymomatous myasthenia gravis patients receiving prednisone","volume":"1132","author":"Newsom-Davis","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.revmed.2013.09.012_bib0290","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1309\/CAV8RNU5TKNACKNC","article-title":"Thymoma classification: current status and future trends","volume":"125","author":"Suster","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.revmed.2013.09.012_bib0295","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/ejcts\/ezs663","article-title":"Thymoma and the increased risk of developing extrathymic malignancies: a multicentre study","volume":"44","author":"Filosso","year":"2013","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.revmed.2013.09.012_bib0300","doi-asserted-by":"crossref","first-page":"5941","DOI":"10.4049\/jimmunol.174.10.5941","article-title":"Effects of cytokines on acetylcholine receptor expression: implications for myasthenia gravis","volume":"174","author":"Poea-Guyon","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.revmed.2013.09.012_bib0305","doi-asserted-by":"crossref","first-page":"7868","DOI":"10.4049\/jimmunol.177.11.7868","article-title":"Microarrays reveal distinct gene signatures in the thymus of seropositive and seronegative myasthenia gravis patients and the role of CC chemokine ligand 21\u00a0in thymic hyperplasia","volume":"177","author":"Le Panse","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.revmed.2013.09.012_bib0310","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1006\/smim.1998.0155","article-title":"Fas\/APO-1\/CD95\u00a0in health and autoimmune disease: thymic and peripheral aspects","volume":"10","author":"Moulian","year":"1998","journal-title":"Semin Immunol"},{"key":"10.1016\/j.revmed.2013.09.012_bib0315","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1182\/blood.V89.9.3287","article-title":"Thymocyte Fas expression is dysregulated in myasthenia gravis patients with anti-acetylcholine receptor antibody","volume":"89","author":"Moulian","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2013.09.012_bib0320","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0896-8411(89)90267-9","article-title":"High recombinant interleukin-2\u00a0sensitivity of peripheral blood lymphocytes from patients with myasthenia gravis: correlations with clinical parameters","volume":"2","author":"Cohen-Kaminsky","year":"1989","journal-title":"J Autoimmun"},{"key":"10.1016\/j.revmed.2013.09.012_bib0325","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0165-5728(94)90080-9","article-title":"Augmented interferon-gamma, interleukin-4\u00a0and transforming growth factor-beta mRNA expression in blood mononuclear cells in myasthenia gravis","volume":"51","author":"Link","year":"1994","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.revmed.2013.09.012_bib0330","doi-asserted-by":"crossref","first-page":"5324","DOI":"10.4049\/jimmunol.174.9.5324","article-title":"Overexpression of IFN-induced protein 10\u00a0and its receptor CXCR3\u00a0in myasthenia gravis","volume":"174","author":"Feferman","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.revmed.2013.09.012_bib0335","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jneuroim.2012.12.001","article-title":"Expansion of circulating counterparts of follicular helper T cells in patients with myasthenia gravis","volume":"256","author":"Luo","year":"2013","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.revmed.2013.09.012_bib0340","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1182\/blood-2003-11-3900","article-title":"Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis","volume":"105","author":"Balandina","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2013.09.012_bib0345","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1749-6632.2012.06791.x","article-title":"Defects of immunoregulatory mechanisms in myasthenia gravis: role of IL-17","volume":"1274","author":"Gradolatto","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.revmed.2013.09.012_bib0350","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1371\/journal.ppat.0020062","article-title":"The thymus is a common target organ in infectious diseases","volume":"2","author":"Savino","year":"2006","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.revmed.2013.09.012_bib0355","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/ana.21902","article-title":"Epstein-Barr virus persistence and reactivation in myasthenia gravis thymus","volume":"67","author":"Cavalcante","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.revmed.2013.09.012_bib0360","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/ana.23791","article-title":"Implication of double-stranded RNA signaling in the etiology of autoimmune myasthenia gravis","volume":"73","author":"Cufi","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1016\/j.revmed.2013.09.012_bib0365","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1375\/twin.14.2.129","article-title":"Utilizing twins concordance rates to infer the predisposition to myasthenia gravis","volume":"14","author":"Ramanujam","year":"2011","journal-title":"Twin Res Hum Genet"},{"key":"10.1016\/j.revmed.2013.09.012_bib0370","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1196\/annals.1405.027","article-title":"Genetic factors in autoimmune myasthenia gravis","volume":"1132","author":"Giraud","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.revmed.2013.09.012_bib0375","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","article-title":"Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity","volume":"8","author":"Meriggioli","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.revmed.2013.09.012_bib0380","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0165-5728(98)00253-7","article-title":"Tumour necrosis factor-alpha polymorphism and secretion in myasthenia gravis","volume":"94","author":"Huang","year":"1999","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.revmed.2013.09.012_bib0385","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/ana.23691","article-title":"Risk for myasthenia gravis maps to a (151) Pro\u2192Ala change in TNIP1\u00a0and to human leukocyte antigen-B*08","volume":"72","author":"Gregersen","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.revmed.2013.09.012_bib0390","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1212\/WNL.0b013e318260cbd0","article-title":"A candidate gene for autoimmune myasthenia gravis","volume":"79","author":"Landoure","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2013.09.012_bib0395","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1749-6632.2012.06789.x","article-title":"Antibodies identified by cell-based assays in myasthenia gravis and associated diseases","volume":"1274","author":"Vincent","year":"2012","journal-title":"Ann N Y Acad Sci"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866313006747?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866313006747?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:33:02Z","timestamp":1759336382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866313006747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":79,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0248866313006747"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2013.09.012","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myasth\u00e9nie et auto-anticorps\u00a0: physiopathologie des diff\u00e9rentes entit\u00e9s","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2013.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Soci\u00e9t\u00e9 nationale fran\u00e7aise de m\u00e9decine interne (SNFMI). Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}